New Triple-Action Drug Helps People With Diabetes Lose Up to 15% of Their Body Weight
An experimental drug that targets three metabolic pathways has shown promising results in people with type 2 diabetes. An experimental drug that targets three metabolic pathways has produced substantial improvements in blood sugar control and weight loss in people with type 2 diabetes. In a phase 3 clinical trial published in The Lancet, participants receiving
Read the full report on Scitechdaily
Story file
- Section
- Health
- Topics
- Health alerts
- First reported by
- Scitechdaily
- Reporter
- the lancet
- Published
- Monday, 19 October 2026, 8:16 pm IST
- Coverage
- One outlet so far
How this page works. The Headline Update lists this report from Scitechdaily with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.
